In Other News

• Gilead’s Remdesivir Delivered Orally in Capsule Could Reduce COVID Hospitalizations

• Low-Cost, Easy-to-Use Breathing Device to Help Cope with Surge in COVID-19 Cases in Poorer Resourced Healthcare Settings

• Pfizer-BioNTech’s Comirnaty Becomes First COVID-19 Vaccine to Receive Full US FDA Approval

• Moderately Ill COVID-19 Patients Treated with Therapeutic-Dose Anticoagulation Have Better Chances of Survival

• Groundbreaking Study Uses AI-Powered Image Cell Analysis to Identify New COVID-19 Drug Available at Local Pharmacies

• Newly-Identified Antibody Proves Highly Protective at Low Doses Against Broad Range of COVID-19 Virus Variants

• Over-the-Counter Acid Suppressant Could Be Secretly Helping People Survive COVID-19

• Aspirin’s Lung-Protective Effects May Decrease Ventilation, ICU Admission and Death in COVID-19 Patients

• Convalescent Plasma Shows No Significant Benefit for COVID-19 Outpatients with Early Symptoms in Latest Study

• New Innovative Method Tests Effectiveness of COVID-19 Drugs for Treatment of SARS-CoV-2 Infection

• FDA Authorizes Third Dose of Pfizer-BioNTech and Moderna COVID-19 Vaccines for Immunocompromised Individuals

• WHO Rolls Out Unprecedented Global Trial to Study New Drugs that Could Lower Mortality in COVID-19 Patients

• Siemens AI-based COVID-19 Severity Algorithm Becomes Available to Help Clinicians Predict Progression to Severe Disease

• Identification of Promising Inhibitors Could Lead to New Antiviral Drugs to Treat COVID-19 Infections

• Highly Advanced AI Model Precisely Detects COVID-19 by Analyzing Lung Images

• Unsupervised AI Model Accurately Predicts COVID-19 Patient's Survival Based on Chest CT Exams

• Regeneron’s Investigational Antibody Cocktail Granted FDA EUA for Preventing COVID-19

• Highly Potent Mini-Antibodies '1000 Times' Better at Neutralizing SARS-CoV-2 Could Be Promising Agents to Treat COVID-19

• Eli Lilly and Incyte’s Baricitinib Reduces Deaths among COVID-19 Patients Receiving Invasive Mechanical Ventilation

• Follow-Up Research Provides Key Insights into COVID-19 Vaccine Efficacy

• Eli Lilly and Incyte’s Baricitinib Receives FDA EUA for Use as Monotherapy in Hospitalized COVID-19 Patients Requiring Oxygen

• Vaccinated Individuals with Lower Level of Antibodies Face Higher Risk of COVID-19 Breakthrough Infections, Finds New Research

• AI COVID-19 Survival Calculator Provides Patient's Risk Score, Expected Time to Death and Survival Probability